Portfolio company
Waiv
France · £27.6m raised
Raised
£27.6m
Latest stage
Series A
Rounds recorded
1
Backed by
6 investors
Sectors
About
This company develops artificial intelligence diagnostic tests and digital pathology software for oncology laboratories and healthcare providers to improve cancer patient treatment decisions.
SourceFunding history · 1
Similar companies
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Ibex Medical
This company develops artificial intelligence software for cancer diagnostics to assist pathologists in labs and hospitals with biopsy analysis and quality control.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
Ibex Medical Analytics
This company develops artificial intelligence platforms for cancer diagnostics to assist pathologists and laboratories with automated biopsy analysis and clinical workflows.
Spotlight Medical
This company develops AI-driven prognosis tests to help oncologists select the most effective treatments for cancer patients.
Viseur AI
This company develops an artificial intelligence platform for medical imaging and digital pathology workflows to assist healthcare professionals in hospitals and diagnostic laboratories.
Artera
This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.
